Methods of TAS and angiographic results in the stenosis group
| Patient/Sex/Age (y) | No. of Used Stents | Dose of Urokinase* | Preprocedure/Postprocedure TIMI† | Prestenosis/Poststenosis (%)‡ | Technical Success | Procedural Dissections or Clots |
|---|---|---|---|---|---|---|
| 17/M/77 | 3 | 0 | 2/3 | 95/10 | Success | Yes |
| 18/M/65 | 0 | 0 | 2/3 | 90/22 | Success | No |
| 19/M/78 | 1 | 0 | 2/3 | 82/0 | Success | Yes |
| 20/M/59 | 0 | 0 | 1/3 | 94/30 | Success | No |
| 21/M/75 | 1 | 0 | 2/3 | 90/12 | Success | Yes |
| 22/M/70 | 0 | 0 | 2/3 | 80/20 | Success | No |
| 23/F/82 | 0 | 0 | 2/2 | 90/90 | Failure | NE |
| 24/M/64 | 0 | 0 | 1/3 | 90/30 | Success | No |
| 25/M/60 | 1 | 0 | 2/3 | 90/6 | Success | Yes |
| 26/M/74 | 1 | 0 | 2/3 | 80/10 | Success | Yes |
| 27/M/78 | 0 | 0 | 2/3 | 84/8 | Success | No |
| 28/M/66 | 1 | 0 | 1/3 | 95/10 | Success | Yes |
Note:—TAS, transluminal angioplasty and/or stenting; M, male; F, female; TIMI, Thrombolysis in Myocardial Infarction; NE, no evaluation.
* Data are 104 units.
† Grading with the TIMI definitions, 0 indicates no perfusion; 1, penetration without perfusion; 2, partial perfusion; and 3, complete perfusion.
‡ Preprocedural and postprocedural stenotic ratio was measured with the warfarin-aspirin symptomatic intracranial disease method.